We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance for the pharmaceutical industry on Marketing Authorisations for veterinary medicines.
Details of certificates issued under the Special Import System for the top ten veterinary medicines that were imported 1 Jan - 31 Mar 2024.
This amended guidance was issued under s 182 of the Licensing Act 2003.
Information to assist with differentiating Lyme disease from other causes of rash, neurological or non-specific symptoms.
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
Information for patients who have been prescribed Lagevrio (molnupiravir), the COVID-19 oral antiviral medication.
Sets out COVID-19 testing for hospice patients and staff.
Background information and advice on coronavirus (COVID-19) for health and care professionals.
Explains changes to drug driving law and the guidance available for healthcare professionals and users of prescription medicine.
Check what side effects people have reported when they've taken a medicine.
How traditional herbal medicines and homeopathic medicines will be treated by the MHRA.
This guidance identifies common issues with validation and assessment of clinical trial applications and how to avoid them.
Guidance for manufacturers, importers and distributors on the Product Security and Telecommunications Infrastructure Act 2022 and Regulations 2023.
Guidance and support on coronavirus (COVID-19) in Scotland.
Information about when you need to submit substantial amendments to a clinical trial including changes to the trial sponsor or legal representative, Investigational medicinal product certification and importation.
Decisions made by MHRA on adverts reported to have breached the legislation on advertising medicines.
We are providing an update on a retrospective observational study on the risk to children born to men who took valproate in the 3 months before conception and on the need for the re-analysis of the data from this study...
How to use an N-of-1 study to evaluate your digital health product.
The characteristics, diagnosis and epidemiology of LGV.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.